Finally, miR-193a was shown to have a tumor-suppressor activity by targeting Caprin1, an upstream activator of the G1/S-specific cyclin-D2 (Ccnd2) and the proto-oncogen transcription factor c-Myc [92]. This evidence concerns the gene CCND2 and neoplasm.